Join the ScanScor Revolution
For decades, investors have relied on gut instinct, hype, and guesswork to chase biotech breakouts. At ScanScor, we’re changing that—one prediction at a time.
Our system continuously analyzes thousands of companies, ranking them by real-world catalysts and generating transparent, AI-powered forecasts. While we’re still early in tracking results, we expect to be publishing data that shows a success rate of better than 50% on our predictions.
This is your chance to be among the first to access these insights—before the rest of the market catches on. Whether you’re a seasoned investor or simply curious about what’s coming next, ScanScor gives you a front-row seat to a new era of intelligent investing.
Be part of the revolution. Track predictions. Measure results. See the future unfold—one breakout at a time.